Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Julphar
UBS
US Army
Fuji
McKesson
Covington
Cerilliant
Boehringer Ingelheim

Generated: December 14, 2018

DrugPatentWatch Database Preview

AMMONIA N 13 Drug Profile

« Back to Dashboard

Which patents cover Ammonia N 13, and when can generic versions of Ammonia N 13 launch?

Ammonia N 13 is a drug marketed by 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens Hosp, Cardinal Health 414, Central Radiopharm, Essential Isotopes, Feinstein, Gen Hosp, Global Isotopes Llc, Houston Cyclotron, Johns Hopkins Univ, Kreitchman Pet Ctr, Mcprf, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Petnet, Precision Nuclear, Shertech Labs Llc, Sofie, Spectron Mrc Llc, Ucla Biomedical, Ucsf Rodiopharm, Univ Tx Md Anderson, Wa Univ Sch Med, and Wi Medcl Cyclotron. and is included in twenty-six NDAs.

The generic ingredient in AMMONIA N 13 is ammonia n-13. There are two drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ammonia n-13 profile page.

Summary for AMMONIA N 13
Drug patent expirations by year for AMMONIA N 13
Pharmacology for AMMONIA N 13
Synonyms for AMMONIA N 13
(13N)Ammoni
(13n)ammonia
[13N]Ammonia
[13N]NH3
13981-22-1
13N-Ammonia
34819-78-8
9OQO0E343Z
AC1L3OST
Ammonia (13N)
Ammonia N 13 (TN)
Ammonia N 13 (USP)
Ammonia N 13 [USAN]
AMMONIA N-13
Ammonia N13
CHEBI:135980
CHEMBL1201189
D02915
DB09326
IN010662
MOLI001000
MOLI001060
Nitrogen-13
Nitrogen, isotope of mass 13
Nitrogen, isotope of mass 13, at.
QGZKDVFQNNGYKY-BJUDXGSMSA-N
UNII-9OQO0E343Z

US Patents and Regulatory Information for AMMONIA N 13

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3d Imaging Drug AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 203779-001 Oct 19, 2015 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Precision Nuclear AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 204547-001 Aug 14, 2015 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Univ Tx Md Anderson AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 203933-001 Jun 27, 2014 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Feinstein AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 022119-001 Aug 23, 2007 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cardinal Health 414 AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 203700-001 Feb 25, 2013 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Kreitchman Pet Ctr AMMONIA N 13 ammonia n-13 INJECTABLE;INTRAVENOUS 203938-001 Dec 9, 2013 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Healthtrust
Harvard Business School
Julphar
US Department of Justice
Cerilliant
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.